ACTIVE SUBSTANCE / INN

TERBINAFINE HYDROCHLORIDE

Brand name(s): TERBINAFINE HYDROCHLORIDE, LAMISIL, LAMISIL AT
FDA LISTED
PRESCRIPTION
OVER-THE-COUNTER
DISCONTINUED
ANDA077136
ANDA077511
ACTIVE SUBSTANCE
Terbinafine Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
ANDRX PHARM, KARO HLTHCARE, NOVARTIS
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TERBINAFINE HYDROCHLORIDEANDA077136MYLANDiscontinued
TERBINAFINE HYDROCHLORIDEANDA077533INVAGEN PHARMSPrescription
LAMISILNDA020539NOVARTISDiscontinued
TERBINAFINE HYDROCHLORIDEANDA076713ANDRX PHARMNone (Tentative Approval)
TERBINAFINE HYDROCHLORIDEANDA077511SUN PHARMA CANADAOver-the-counter
LAMISILNDA020980KARO HLTHCAREOver-the-counter
LAMISIL ATNDA021124KARO HLTHCAREOver-the-counter

FULL INTELLIGENCE ON TERBINAFINE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →